Bruce E. Sands

Gastroenterology

1 Gustave L Levy Pl
New York, NY 10029

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 338 publications

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

Journal: medRxiv : the preprint server for health sciences

Published: May 25, 2026

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Journal: Journal of Crohn's & colitis

Published: May 20, 2026

Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.

Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).

In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).

Journal: Gastroenterology

Published: April 12, 2026

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 01, 2026

Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: March 27, 2026

IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease.

IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: March 09, 2026

IOIBD: the International Organization for the Study of Inflammatory Bowel Disease.

IOIBD: the International Organization for the Study of Inflammatory Bowel Disease.

Journal: Therapeutic advances in gastroenterology

Published: February 15, 2026

In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).

In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).

Journal: Gastroenterology

Published: February 13, 2026

Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.

Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.

Journal: Therapeutic advances in gastroenterology

Published: January 06, 2026

Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.

Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.

Journal: The lancet. Gastroenterology & hepatology

Published: December 18, 2025

Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

Journal: Inflammatory bowel diseases

Published: December 18, 2025

Showing 1-12 of 338

Last Updated: 09/26/2026